文献速递神经肿瘤

图像引导调强质子治疗在胶质瘤中的作用

The role of image-guided intensity modulated proton therapy in glioma.
PubMed 文献 · Neuro Oncol · 2017-01-01

胶质瘤预后跨度从数月到数十年,放疗是重要治疗手段但可能导致认知损伤。调强质子治疗(IMPT)作为最新质子技术,可能增加正常组织保护并减少不良反应,对侵袭性肿瘤或允许剂量提升,但其获益尚未被证实。

要点

  • 胶质瘤预后差异大,放疗可改善疾病控制和生存,但可能导致认知损伤。
  • IMPT是最新质子技术,可增加正常组织保护并减少不良反应。
  • 对侵袭性肿瘤,IMPT的剂量适形性可能允许靶区剂量提升。

核心结论

  • 对预后好和预后差的胶质瘤患者,IMPT可能提供显著但尚未被证实的获益。
  • 为真正最大化IMPT的临床潜力,放射肿瘤学领域不仅需实施最先进技术,还需理解并利用质子治疗的独特生物学特性。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 胶质瘤预后从数月到数十年不等。
  • 放疗在胶质瘤治疗中起关键作用,改善疾病控制并常改善生存,但放射诱导的认知损伤可能负面影响生存者生活质量。
  • IMPT是最新且最先进的质子递送技术,与历史质子技术相比有实质性优势。
  • IMPT可最大化质子的物理优势,增加正常组织保护并减少潜在不良反应。
  • 对更具侵袭性的肿瘤,IMPT提供的剂量适形性和正常组织保护可能允许靶区剂量提升。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • IMPT的获益尚未被证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gliomas represent a broad spectrum of disease with life-expectancy outcomes ranging from months to decades. As our understanding of the molecular profiles of gliomas expands rapidly, practitioners are now better able to identify patients with favorable versus nonfavorable prognoses. Radiation therapy plays a key role in glioma treatment, improving disease control and oftentimes survival. However, for survivors, either long-term or short-term, radiation-induced cognitive impairments may negatively impact their quality of life. For patients with both favorable and unfavorable prognoses, intensity modulated proton therapy (IMPT) may offer significant, yet unproven benefits. IMPT is the newest and most advanced proton delivery technique, one with substantial benefits compared with historical proton techniques. IMPT allows practitioners to maximize the physical benefits of protons, increasing normal tissue sparing and reducing the potential for adverse effects. For more aggressive tumors, the dose conformality and normal tissue sparing afforded by IMPT may also allow for dose escalation to target volumes. However, in order to truly maximize the clinical potential of IMPT, the field of radiation oncology must not only implement the most advanced technologies, but also understand and capitalize on the unique biologic aspects of proton therapy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Grosshans DR, Mohan R, Gondi V, et al. The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol. 2017. PMID: 28380636. doi:10.1093/neuonc/nox002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。